Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer : definition of a high-risk group and estimation of the lead time
(c) 2006 Wiley Periodicals, Inc..
BACKGROUND: All patients treated for laryngeal cancer are offered the same follow-up schedule to detect asymptomatic locoregional recurrences. In this study, we evaluated the prognostic profile of patients for cancer recurrence and estimated the lead time.
METHODS: A cohort study was performed between 1990 and 1995. Cox proportional hazards model was used to analyze the prognostic factors. The effect of altering the follow-up for asymptomatic recurrence detection was determined after estimating the lead time.
RESULTS: The variables cT classification, smoking, and histologic grade proved to be prognostic factors. The risk of locoregional failure was 15% in the low-risk group versus 29% in the high-risk group. The estimated lead time was 2 to 4 weeks.
CONCLUSION: Risk profiles for locoregional relapse were defined. Intensifying the follow-up schedule is not advisable because the lead time is very short. An excessively high number of routine visits would have to be performed to increase the detection rate for asymptomatic recurrences.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2007 |
|---|---|
| Erschienen: |
2007 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Head & neck - 29(2007), 5 vom: 20. Mai, Seite 431-8 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Ritoe, Savitri C [VerfasserIn] |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 19.06.2007 Date Revised 16.03.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM166733482 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM166733482 | ||
| 003 | DE-627 | ||
| 005 | 20231223111426.0 | ||
| 007 | tu | ||
| 008 | 231223s2007 xx ||||| 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n0556.xml |
| 035 | |a (DE-627)NLM166733482 | ||
| 035 | |a (NLM)17120311 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Ritoe, Savitri C |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer |b definition of a high-risk group and estimation of the lead time |
| 264 | 1 | |c 2007 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 19.06.2007 | ||
| 500 | |a Date Revised 16.03.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a (c) 2006 Wiley Periodicals, Inc. | ||
| 520 | |a BACKGROUND: All patients treated for laryngeal cancer are offered the same follow-up schedule to detect asymptomatic locoregional recurrences. In this study, we evaluated the prognostic profile of patients for cancer recurrence and estimated the lead time | ||
| 520 | |a METHODS: A cohort study was performed between 1990 and 1995. Cox proportional hazards model was used to analyze the prognostic factors. The effect of altering the follow-up for asymptomatic recurrence detection was determined after estimating the lead time | ||
| 520 | |a RESULTS: The variables cT classification, smoking, and histologic grade proved to be prognostic factors. The risk of locoregional failure was 15% in the low-risk group versus 29% in the high-risk group. The estimated lead time was 2 to 4 weeks | ||
| 520 | |a CONCLUSION: Risk profiles for locoregional relapse were defined. Intensifying the follow-up schedule is not advisable because the lead time is very short. An excessively high number of routine visits would have to be performed to increase the detection rate for asymptomatic recurrences | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Verbeek, André L M |e verfasserin |4 aut | |
| 700 | 1 | |a Krabbe, Paul F M |e verfasserin |4 aut | |
| 700 | 1 | |a Kaanders, Johannes H A M |e verfasserin |4 aut | |
| 700 | 1 | |a van den Hoogen, Frank J A |e verfasserin |4 aut | |
| 700 | 1 | |a Marres, Henri A M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Head & neck |d 1996 |g 29(2007), 5 vom: 20. Mai, Seite 431-8 |w (DE-627)NLM012791806 |x 1097-0347 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2007 |g number:5 |g day:20 |g month:05 |g pages:431-8 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2007 |e 5 |b 20 |c 05 |h 431-8 | ||